Mode
Text Size
Log in / Sign up
N/A Completed N=52 Randomized Double-blind Treatment

Dispensing Evaluation of a Prototype Contact Lens and a Marketed Contact Lens

Source: ClinicalTrials.gov NCT01094743 ↗
Enrolled (actual)
52
Serious AEs
0.0%
Results posted
Jan 2012
Primary outcomePrimary: Visual Acuity Monocular — 59; 64; 40; 30 eyes

Summary

The purpose of this study is to compare visual acuity and redness of eyes between a prototype contact lens and an already marketed contact lens.

Outcome Measures

OutcomeResultp-value
PRIMARY
Visual Acuity Monocular
59; 64; 40; 30; 1; 5 —
PRIMARY
Visual Acuity Binocular
40; 42; 10; 8 —
PRIMARY
Subjective Assessment of Lens Comfort
76.67; 65 —
PRIMARY
Subjective Assessment of Quality of Vision
63.22; 59.83 —
SECONDARY
Limbal Redness
37; 35; 61; 61; 2; 4 —
SECONDARY
Bulbar Redness
44; 34; 50; 64; 6; 2 —
SECONDARY
Subjective Assessment of Lens Comfort
76.67; 65 —

Eligibility Criteria

Inclusion Criteria

  • The subject must be at least 18 years of age and no more than 39 years of age.
  • The subject is a current spherical soft contact lens wearer (defined as a minimum of 6 hours of DW for a minimum of 1 month prior to the study) and willing to wear the study lenses on a daily wear basis (defined as a minimum of 6 hours of wear per day at least five days of the week) for the duration of the study.
  • The subject's optimal vertexed spherical equivalent distance correction must be between -1.00 and - 9.00D.
  • Any cylinder power must be ≤ -0.75D.
  • The subject must have visual acuity best correctable to 20/25+3 or better for each eye.
  • The subject must read and sign the Statement of Informed Consent.
  • The subject must appear able and willing to adhere to the instructions set forth in this clinical protocol.

Exclusion Criteria

  • Ocular or systemic allergies or disease which might interfere with contact lens wear.
  • Systemic disease or use of medication which might interfere with contact lens wear.
  • Clinically significant (grade 3 or 4) corneal edema, corneal vascularization, corneal staining, or any other abnormalities of the cornea which would contraindicate contact lens wear.
  • Clinically significant (grade 3 or 4) tarsal abnormalities or bulbar injection which might interfere with contact lens wear.
  • Any ocular infection.
  • Any corneal distortion resulting from previous hard or rigid gas permeable contact lens wear.
  • Pregnancy or lactation.
  • Diabetes.
  • Infectious diseases (e.g. hepatitis, tuberculosis) or an immuno-suppressive disease (e.g. HIV).
  • Habitual contact lens type is toric, multifocal, or is worn as extended wear.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01094743). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search